Irradiation in the Production, Processing and Handling of Food, 39557-39560 [E7-13947]
Download as PDF
Federal Register / Vol. 72, No. 138 / Thursday, July 19, 2007 / Rules and Regulations
The Special Conditions
Accordingly, pursuant to the authority
delegated to me by the Administrator,
the following special conditions are
issued as part of the type certification
basis for SA160 Avidyne Entegra
Avionics Suite Project airplane
modified by Symphony Aircraft
Industries, Inc. to add an EFIS.
1. Protection of Electrical and
Electronic Systems from High Intensity
Radiated Fields (HIRF). Each system
that performs critical functions must be
designed and installed to ensure that the
operations, and operational capabilities
of these systems to perform critical
functions, are not adversely affected
when the airplane is exposed to high
intensity radiated electromagnetic fields
external to the airplane.
2. For the purpose of these special
conditions, the following definition
applies:
Critical Functions: Functions whose
failure would contribute to, or cause, a
failure condition that would prevent the
continued safe flight and landing of the
airplane.
I
a hearing or otherwise provide a basis
for revoking or modifying the
amendment to the regulation.
FOR FURTHER INFORMATION CONTACT:
Andrew J. Zajac, Center for Food Safety
and Applied Nutrition (HFS–265), Food
and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD 20740–
3835, 301–436–1267.
SUPPLEMENTARY INFORMATION:
I. Introduction
21 CFR Part 179
In the Federal Register of February
24, 1994 (59 FR 8995), FDA published
a notice announcing the filing of a
petition (FAP 4M4407) submitted by
Analytical Systems Engineering Corp.
(ASEC) (now ACS Defense, Inc.) to
amend the food additive regulations in
§ 179.21 Sources of radiation used for
inspection of food, for inspection of
packaged food, and for controlling food
processing (21 CFR 179.21) to provide
for the safe use of machine sources of
high energy x-rays to inspect cargo
containers that may contain food. The
rights to the petition were subsequently
transferred to R. F. Reiter and
Associates. In response to the petition,
FDA issued a final rule in the Federal
Register of April 10, 2001 (66 FR
18537), permitting the use of x-rays
produced by machine sources of 10
million electron volts (MeV) or lower to
inspect food, providing that no food
receives a dose in excess of 0.5 gray
(Gy). This rule will be referred to in this
document as the ‘‘cargo inspection final
rule.’’ The preamble to the final rule
advised that objections to the final rule
and requests for a hearing were due
within 30 days of the publication date
(i.e., by May 10, 2001).
[Docket No. 1994F–0008 (formerly Docket
No. 94F–0008)]
II. Objections and Requests for a
Hearing
Issued in Kansas City, Missouri, on July 6,
2007.
David R. Showers,
Acting Manager, Small Airplane Directorate,
Aircraft Certification Service.
[FR Doc. E7–14050 Filed 7–18–07; 8:45 am]
BILLING CODE 4910–13–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Irradiation in the Production,
Processing and Handling of Food
AGENCY:
Food and Drug Administration,
HHS.
Final rule; response to
objections and denial of requests for a
hearing.
cprice-sewell on PROD1PC66 with RULES
ACTION:
SUMMARY: The Food and Drug
Administration (FDA) is responding to
objections and is denying the requests
that it has received for a hearing on the
final rule that amended the food
additive regulations to authorize the use
of a machine source of high energy xrays to inspect cargo containers that
may contain food. After reviewing the
objections to the final rule and the
requests for a hearing, the agency has
concluded that the objections do not
raise issues of material fact that justify
VerDate Aug<31>2005
13:36 Jul 18, 2007
Jkt 211001
Section 409(f) of the Federal Food,
Drug, and Cosmetic Act (the act) (21
U.S.C. 348(f)), provides that, within 30
days after publication of an order
relating to a food additive regulation,
any person adversely affected by such
order may file objections, ‘‘specifying
with particularity the provisions of the
order deemed objectionable, stating
reasonable grounds therefor, and
requesting a public hearing upon such
objections.’’ FDA may deny a hearing
request if the objections to the
regulation do not raise genuine and
substantial issues of fact that can be
resolved at a hearing. (Community
Nutrition Institute v. Young, 773 F. 2d
1356, 1364 (D.C. Cir. 1985), cert. denied,
475 U.S. 1123 (1986)).
Under the food additive regulations at
21 CFR 171.110, objections and requests
for a hearing are governed by part 12 (21
PO 00000
Frm 00003
Fmt 4700
Sfmt 4700
39557
CFR part 12) of FDA’s regulations.
Under § 12.22(a), each objection must
meet the following conditions: (1) Must
be submitted on or before the 30th day
after the date of publication of the final
rule; (2) must be separately numbered;
(3) must specify with particularity the
provision of the regulation or proposed
order objected to; (4) must specifically
state each objection on which a hearing
is requested; failure to request a hearing
on an objection constitutes a waiver of
the right to a hearing on that objection;
and (5) must include a detailed
description and analysis of the factual
information to be presented in support
of the objection if a hearing is requested;
failure to include a description and
analysis for an objection constitutes a
waiver of the right to a hearing on that
objection.
Following publication of the cargo
inspection final rule, FDA received a
letter from Public Citizen within the 30day objection period. Public Citizen
sought revocation of the final rule based
on three objections and requested a
hearing on issues raised by each
objection.
III. Standards for Granting a Hearing
Specific criteria for deciding whether
to grant or deny a request for a hearing
are set out in § 12.24(b). Under that
regulation, a hearing will be granted if
the material submitted by the requester
shows, among other things, the
following: (1) There is a genuine and
substantial factual issue for resolution at
a hearing; a hearing will not be granted
on issues of policy or law; (2) the factual
issue can be resolved by available and
specifically identified reliable evidence;
a hearing will not be granted on the
basis of mere allegations or denials or
general descriptions of positions and
contentions; (3) the data and
information submitted, if established at
a hearing, would be adequate to justify
resolution of the factual issue in the way
sought by the requestor; a hearing will
be denied if the data and information
submitted are insufficient to justify the
factual determination urged, even if
accurate; (4) resolution of the factual
issue in the way sought by the person
is adequate to justify the action
requested; a hearing will not be granted
on factual issues that are not
determinative with respect to the action
requested (e.g., if the action would be
the same even if the factual issue were
resolved in the way sought); (5) the
action requested is not inconsistent with
any provision in the act or any FDA
regulation; and (6) the requirements in
other applicable regulations, e.g., 21
CFR 10.20, §§ 12.21 and 12.22, and in
the notice issuing the final requlation or
E:\FR\FM\19JYR1.SGM
19JYR1
cprice-sewell on PROD1PC66 with RULES
39558
Federal Register / Vol. 72, No. 138 / Thursday, July 19, 2007 / Rules and Regulations
the notice of opportunity for hearing are
met.
A party seeking a hearing is required
to meet a ‘‘threshold burden of
tendering evidence suggesting the need
for a hearing’’ (Costle v. Pacific Legal
Foundation, 445 U.S. 198, 214–215
(1980), reh. denied, 446 U.S. 947 (1980),
citing Weinberger v. Hynson, Westcott &
Dunning, Inc., 412 U.S. 609, 620–621
(1973)). An allegation that a hearing is
necessary to ‘‘sharpen the issues’’ or to
‘‘fully develop the facts’’ does not meet
this test (Georgia Pacific Corp. v. EPA,
671 F.2d 1235, 1241 (9th Cir. 1982)). If
a hearing request fails to identify any
factual evidence that would be the
subject of a hearing, there is no point in
holding one. In judicial proceedings, a
court is authorized to issue summary
judgment without an evidentiary
hearing whenever it finds that there are
no genuine issues of material fact in
dispute and a party is entitled to
judgment as a matter of law (see Rule
56, Federal Rules of Civil Procedure).
The same principle applies in
administrative proceedings (see § 12.28).
A hearing request must not only
contain evidence, but that evidence
should raise a material issue of fact
concerning which a meaningful hearing
might be held (Pineapple Growers Ass’n
v. FDA, 673 F.2d 1083, 1085 (9th Cir.
1982)). Where the issues raised in the
objection are, even if true, legally
insufficient to alter the decision, the
agency need not grant a hearing (see
Dyestuffs and Chemicals, Inc. v.
Flemming, 271 F.2d 281 (8th Cir. 1959),
cert. denied, 362 U.S. 911 (1960)). FDA
need not grant a hearing in each case
where an objector submits additional
information or posits a novel
interpretation of existing information
(see United States v. Consolidated
Mines & Smelting Co., 455 F.2d 432 (9th
Cir. 1971)). In other words, a hearing is
justified only if the objections are made
in good faith and if they ‘‘draw in
question in a material way the
underpinnings of the regulation at
issue’’ (Pactra Industries v. CPSC, 555
F.2d 677 (9th Cir. 1977)). Finally, courts
have uniformly recognized that a
hearing need not be held to resolve
questions of law or policy (see Citizens
for Allegan County, Inc. v. FPC, 414
F.2d 1125 (D.C. Cir. 1969); Sun Oil Co.
v. FPC, 256 F.2d 233, 240 (5th Cir.), cert.
denied, 358 U.S. 872 (1958)).
Even if the objections raise material
issues of fact, FDA need not grant a
hearing if those same issues were
adequately raised and considered in an
earlier proceeding. Once an issue has
been so raised and considered, a party
is estopped from raising that same issue
in a later proceeding without new
VerDate Aug<31>2005
13:36 Jul 18, 2007
Jkt 211001
evidence. The various judicial doctrines
dealing with finality can be validly
applied to the administrative process. In
explaining why these principles ‘‘selfevidently’’ ought to apply to an agency
proceeding, the U.S. Court of Appeals
for the District of Columbia Circuit
wrote: ‘‘The underlying concept is as
simple as this: Justice requires that a
party have a fair chance to present his
position. But overall interests of
administration do not require or
generally contemplate that he will be
given more than a fair opportunity.’’
Retail Clerks Union, Local 1401 v.
NLRB, 463 F.2d 316, 322 (D.C. Cir.
1972). (See Costle v. Pacific Legal
Foundation, supra at 215–220. See also
Pacific Seafarers, Inc. v. Pacific Far East
Line, Inc., 404 F.2d 804 (D.C. Cir. 1968),
cert denied, 393 U.S. 1093 (1969).)
In summary, a hearing request must
present sufficient credible evidence to
raise a material issue of fact and the
evidence must be adequate to resolve
the issue as requested and to justify the
action requested.
IV. Analysis of Objections and
Response to Hearing Requests
The objections to the cargo inspection
final rule pertain to FDA’s safety
determination. FDA addresses each of
the objections below, as well as the data
and information filed in support of
each, comparing each objection and the
information submitted in support of it to
the standards for granting a hearing in
§ 12.24.
A. Safety of Irradiation for Inspection of
Cargo Containers
Under 21 CFR 170.3(i), safety of a
food additive means that there is a
reasonable certainty in the minds of
competent scientists that the substance
is not harmful under the intended
conditions of use. FDA’s regulations
reflect the congressional judgment that
the additive must be properly tested and
such tests carefully evaluated, but that
the additive need not, indeed cannot, be
shown to be safe to an absolute
certainty. The House Report on the Food
Additives Amendment of 1958 stated:
‘‘Safety requires proof of a reasonable
certainty that no harm will result from
the proposed use of the additive. It does
not—and cannot—require proof beyond
any possible doubt that no harm will
result under any conceivable
circumstance’’ (H. Rept. 2284, 85th
Cong., 2d sess., 1958).
The cargo inspection final rule
discussed in detail FDA’s evaluation of
the safety of radiation for inspection of
cargo containers that may contain food
(66 FR 18537). Under that regulation,
machine sources producing x-rays at
PO 00000
Frm 00004
Fmt 4700
Sfmt 4700
energies no greater than 10 MeV may be
used to inspect containers of food,
provided that the absorbed dose not
exceed 0.5 Gy.
Among the reports submitted in the
petition or that FDA identified in
scientific publications, the agency
explicitly cited three in its final rule.
These reports, which were among the
most recent studies or reviews, assessed
the potential for induced radioactivity
in food by experimental measurement
and theoretical calculation, and
provided the primary basis for FDA’s
conclusion regarding safety of the
petitioned use of 10 MeV x-rays at a
dose not to exceed 0.5 Gy.
One of the reports is from the World
Health Organization (WHO). This WHO
report concluded that no detectable
radioactivity will be induced in
foodstuffs by x-rays with a maximum
energy level of 10 MeV when a radiation
dose of 0.5 Gy is not exceeded.
The second report (Wakeford and
Blackburn, 1991) discussed a study
investigating the radioactivity induced
in codfish, rice, and a macerated meat
product irradiated with high energy
bremsstrahlung1 x-rays produced by an
electron linear accelerator that
generated electrons at energies up to 12
MeV and predominantly at 8 MeV. The
authors reported that the
bremsstrahlung x-rays used to irradiate
the food had a maximum energy in the
region of 10 MeV. These foods received
radiation doses ranging from 8.8 to 14
kilogray (kGy), which is 17,600 to
28,000 times higher than the 0.5 Gy
maximum dose permitted by the final
rule. Induced activities in the foods
from the bremsstrahlung x-rays were
reported to be extremely small and of
the same order as natural background
levels, and any induced activities
dropped quickly.
The third report (Findlay et al., 1992)
summarized a study that investigated
the induced radioactivity in chicken,
prawns, cheeses, and spices irradiated
with electron beams at two energies, 10
MeV and 20 MeV and at different doses
up to 10 kGy. The authors noted that
any induced radioactivity was due to
photonuclear reactions resulting from
bremsstrahlung x-rays and
electronuclear reactions induced by the
electron beams. The authors found that
even when the food was irradiated with
1Bremsstrahlung refers to the type of x-rays that
are emitted when high-speed electrons are suddenly
decelerated due to interactions with atomic nuclei.
X-rays also can be produced when accelerated
electrons have sufficient energy to eject electrons
from the inner shells of atoms. As outer-shell
electrons move in to fill the vacancies in the lower
energy level, x-rays are emitted, called
characteristic x-rays.
E:\FR\FM\19JYR1.SGM
19JYR1
Federal Register / Vol. 72, No. 138 / Thursday, July 19, 2007 / Rules and Regulations
electrons at 20 MeV and doses at 10
kGy, the highest energy and dose tested,
any induced activity was negligible after
1 day.2 The authors reported that the
measured values agreed well with
calculated values. Based on the totality
of the data and other relevant material
evaluated by FDA, the agency
concluded that no detectable
radioactivity will be induced in food
when an x-ray energy of 10 MeV and a
dose of 0.5 Gy are not exceeded, and
that the use of x-rays, produced by a
machine source at energies of 10 MeV
or lower, to inspect food, is safe.
cprice-sewell on PROD1PC66 with RULES
B. Objections
Public Citizen contends that FDA has
failed to demonstrate that the use of the
subject additive is safe and gives three
reasons for objecting to the final rule.
Public Citizen requests a public hearing
on their objections.
First, Public Citizen contends that
FDA’s use of the conclusion in the WHO
report that ‘‘no detectable radioactivity
will be induced in foodstuffs when an
x-ray energy level of 10 MeV and a dose
of 0.5 Gy are not exceeded’’ is flawed
because the conclusion is based on an
extrapolation of theoretical and
experimental studies that the report
does not reference.
The WHO report states that
‘‘* * * relevant experimental data are
available from studies designed to
evaluate the use of activation analysis
and the application of x-rays and
electrons in food irradiation and
medical uses at energy levels up to 24
MeV and at doses up to 50 kGy. Such
studies, both theoretical and
experimental, can be used to extrapolate
downwards to a lower dose such as the
0.5 Gy considered for surveillance
systems and that these studies show no
evidence that detectable levels of
radioactivity would be induced at these
lower doses.’’ Although not specifically
cited, it is clear that the experimental
data referred to in the report are the data
from studies that were discussed in
several working papers that were
presented to the WHO consultation
group and several relevant published
papers referenced in the WHO report.
These working papers were included in
the petition along with the WHO report.
For example, one paper that discussed
experimental and theoretical work
concerning the possible induction of
radionuclides in food by high energy xray systems used for cargo surveillance
referenced several relevant studies,
2 The authors reported a specific activity after 1
day of 0.01 becquerel/gram.
VerDate Aug<31>2005
13:36 Jul 18, 2007
Jkt 211001
including one by Glass and Smith.3 This
particular study, which was submitted
with the petition, examined isomer
radioactivities in elements and food
using a variety of radiation sources,
including 4–24 MeV x-ray sources at
doses up to 50 kGy. FDA is denying the
request for a hearing on this point
because a hearing will not be granted if
there is no genuine and substantial
factual issue to be resolved
(§ 12.24(b)(1)).
Public Citizen has failed to submit
any evidence that would call into
question the scientific validity of
extrapolation of results obtained at
higher energy levels and radiation doses
to draw conclusions regarding effects
that might be produced at lower energy
levels and doses. Public Citizen is
merely alleging that this approach is
scientifically unsound. FDA is denying
the request for a hearing on this point
because a hearing will not be granted on
the basis of mere allegations or denials
or general descriptions of positions or
contentions (§ 12.24(b)(2)).
In its second objection, Public Citizen
contends that the Wakeford report is
cited in the final rule to support the
statement that electrons with energies of
8–10 MeV induced an extremely small
level of radioactivity in various types of
food, but that this statement is irrelevant
to this petition because the petition
concerns the use of x-rays. The
objection further asserts that the
statement in the final rule ‘‘FDA would
not expect any detectable radioactivity
above background in food resulting from
the petitioned use,’’ is based on no data
or evidence.
Contrary to Public Citizen’s
contention, the Wakeford report did
concern the use of x-rays. As referenced
in the final rule, the report by Wakeford,
Blackburn, and Swallow (FDA
inadvertently omitted the name of the
third co-author, A.J. Swallow), titled
‘‘Induction and Detection of
Radioactivity in Foodstuffs Irradiated
with 10 MeV Electrons and X-rays,’’
studied food irradiated with electron
beams as well as with high energy
bremsstrahlung x-rays. The authors state
that the food was irradiated directly by
0–10 MeV x-rays to a maximum dose of
15–20 kGy (the results table shows an
average dose ranging from 8.8 to 14 kGy,
which is 17,600 to 28,000 times higher
than the maximum permitted dose level
under the final rule of 0.5 Gy). The
authors concluded that the induced
activity from the 0–10 MeV
3 R.A. Glass and H.D. Smith, ‘‘Radioactive Isomer
Production in Foods by Gamma Rays and X-rays,’’
Stanford Research Institute Report S–594, No. 3 (DA
19–129–1QM–1511), 1960.
PO 00000
Frm 00005
Fmt 4700
Sfmt 4700
39559
bremsstrahlung x-rays was extremely
small. Public Citizen provided no
information to support its contention
that the radiation reported as x-rays in
the Wakeford report is irrelevant to the
safety review of the subject additive.
FDA is denying the request for a hearing
on this point because a hearing will not
be held on the basis of mere allegations
or denials or general descriptions of
positions or contentions (§ 12.24(b)(2)).
Similarly, the objection does not
identify any evidence to support its
assertion that FDA’s conclusion is based
on no data or evidence. The data and
evidence relied upon by FDA is set out
in the final rule. The Wakeford report,
the WHO report and Findlay report are
all part of the data relied upon by FDA
in making its determination. FDA is
denying the request for a hearing on this
point because a hearing will not be held
on the basis of mere allegations or
denials or general descriptions of
positions or contentions (§ 12.24(b)(2)).
Public Citizen also states in its second
objection that, according to the
Wakeford report, x-rays of energy
greater than 3 MeV could induce
radioactivity, and four isotopes can be
activated at x-ray energies below 5 MeV
and cause neutron induced activity in
food. Among the four isotopes, Public
Citizen specifically mentions carbon-13,
oxygen-17, and deuterium. The
objection does not show that FDA failed
to consider important information that
would have altered the agency’s
conclusion that the x-rays at energies up
to 10 MeV at the maximum proposed
dose of 0.5 Gy will result in negligible
amounts of induced radioactivity in
food. Indeed, the WHO report cited in
the final rule concluded that thresholds
for inducing radioactivity in some
isotopes is less than 10 MeV, but that
the probability of radioactivity being
induced under these conditions is so
low that it would not be detected by
methods that can determine activity that
is only 1 percent of what occurs
naturally in food. The language from the
Wakeford report cited in the objection is
consistent with the conclusions in the
WHO report. Public Citizen identifies
no information to support a conclusion
contrary to that reached by FDA.
Therefore, FDA is denying the request
for a hearing on this point because a
hearing will not be held if there is no
factual issue that can be resolved by
available and specifically identified
reliable evidence (§ 12.24(b)(2)).
In its third objection, Public Citizen
states that the Findlay report is not
relevant to the petition because
induction of radioactivity in food was
studied using electron beams whereas
the petition concerns the use of x-rays.
E:\FR\FM\19JYR1.SGM
19JYR1
cprice-sewell on PROD1PC66 with RULES
39560
Federal Register / Vol. 72, No. 138 / Thursday, July 19, 2007 / Rules and Regulations
In support of its assertion, Public
Citizen references a report from the
International Consultative Group on
Food Irradiation titled ‘‘The
Development of X-Ray Machines for
Food Irradiation (Proceedings of a
Consultants’ Meeting),’’ dated October
1995 (ICGFI report), for its statement
that ‘‘neutron activity produced by 5
MeV x-rays is in the order of 60 times
greater than that produced by 10 MeV
electrons.’’
However, contrary to Public Citizen’s
objection, the ICGFI report shows that
the difference in expected neutron
activation in irradiated food from
electron beams and x-rays has been
calculated, thereby permitting use of
electron beam studies to estimate
neutron activation expected from
irradiation with x-rays. Public Citizen
has offered no evidence to support its
assertion that electron beam studies are
inappropriate to support conclusions
about x-ray irradiation. FDA is denying
the request for a hearing on this point
because the evidence submitted by
Public Citizen in support of their
argument, even if established at a
hearing, would not be adequate to
justify resolution of the factual issue in
the way sought by the objector
(§ 12.24(b)(3)).
Moreover, it bears noting that the
ICGFI report directly supports FDA’s
conclusion of safety in the final rule,
when it cites 10 MeV x-rays at doses
less than 0.5 Gy (the maximum energy
and dosage in the final rule) as an
example of ‘‘extremely low’’ dosage that
‘‘would not produce any significant
radioactivity.’’ Public Citizen’s reference
to the conclusion in the ICGFI report
that ‘‘increasing the energy of x-rays
above 7.5 MeV would result in * * *
possible induction of radioactivity in
the irradiated food’’ is unavailing
because that conclusion refers to the
uses permitted by the Codex
Alimentarius Commission for treating
food at dosages up to 10 kGy, which is
20,000 times higher than the 0.5 Gy
maximum dosage permitted by the final
rule for inspecting food.
Although Public Citizen alleged that
the studies that FDA evaluated do not
support the safety of x-rays of 10 MeV
or lower used for inspection of cargo
containers that may contain food, Public
Citizen did not present any evidence
that would have led to a different
conclusion concerning the safety of the
subject additive. Because Public
Citizen’s first and second objections
provided no information to support
their assertions regarding FDA’s safety
review, they provide no basis for FDA
to reconsider its decision to issue the
cargo inspection final rule. As noted
VerDate Aug<31>2005
13:36 Jul 18, 2007
Jkt 211001
previously, a hearing will not be granted
on the basis of general descriptions of
positions and contentions (see
§ 12.24(b)(1) and (b)(2)). Public Citizen’s
third objection relied on information
that, even if established at a hearing,
would not be adequate to justify
resolution of the factual issue in the way
sought by the objector. A hearing will be
denied if the information submitted are
insufficient to justify the factual
determination urged, even if accurate
(§ 12.24(b)(3)). The issues posed by
Public Citizen in support of the
objections do not justify the granting of
a hearing.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
V. Summary and Conclusions
SUMMARY: The Food and Drug
Administration (FDA) is amending the
regulations for food additives permitted
(FAP) in feed to provide for the safe use
of selenium yeast as a source of
supplemental selenium in feed
supplements for limit feeding for beef
cattle and in salt mineral mixes for freechoice feeding for beef cattle. This
action is in response to an amendment
of a food additive petition filed by
Alltech, Inc.
DATES: This rule is effective July 19,
2007. Submit written or electronic
objections and requests for a hearing by
August 20, 2007. See section V of this
document for information on the filing
of objections.
ADDRESSES: You may submit written or
electronic objections and requests for a
hearing identified by Docket No. 1998F–
0196, by any of the following methods:
Electronic Submissions
Submit electronic objections in the
following ways:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Agency Web site: https://
www.fda.gov/dockets/ecomments.
Follow the instructions for submitting
comments on the agency Web site.
Written Submissions
Submit written objections in the
following ways:
• Fax: 301–827–6870.
• Mail/Hand delivery/Courier [For
paper, disk, or CD–ROM submissions]:
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852.
To ensure more timely processing of
objections, FDA is no longer accepting
objections submitted to the agency by email. FDA encourages you to continue
to submit electronic objections by using
the Federal eRulemaking Portal or the
agency Web site, as described in the
Electronic Submissions portion of this
paragraph.
The safety of x-rays produced by a
machine source at energies of 10 MeV
or lower, to inspect food irradiated at
doses up to 0.5 Gy has been thoroughly
tested, and the data have been reviewed
by the agency. As discussed previously,
FDA concluded that the available
studies establish the safety of food for
human consumption irradiated at doses
up to 0.5 Gy as a result of being
subjected to x-rays produced by a
machine source at energies of 10 MeV
or lower. The petitioner has the burden
to demonstrate safety before FDA can
approve the use of a food additive.
Nevertheless, once the agency makes a
finding of safety in an approval
document, the burden shifts to an
objector, who must come forward with
evidence that calls into question FDA’s
conclusion (American Cyanamid Co. v.
FDA, 606 F. 2d 1307, 1314–1315 (D.C.
Cir. 1979)). For the reasons set out
previously, the objections do not raise
genuine and substantial issues of fact
supported by specifically identified
reliable evidence that, if established at
a hearing would be adequate to justify
resolution in the way sought by Public
Citizen. Therefore, Public Citizen’s
objections are not sufficient to justify a
hearing under the requirements of
§ 12.24(b). Accordingly, FDA is
overruling the objections and is denying
the requests for a hearing.
Dated: July 11, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–13947 Filed 7–18–07; 8:45 am]
BILLING CODE 4160–01–S
PO 00000
Frm 00006
Fmt 4700
Sfmt 4700
Food and Drug Administration
21 CFR Part 573
[Docket No. 1998F–0196] (Formerly 98F–
0196)
Food Additives Permitted in Feed and
Drinking Water of Animals; Selenium
Yeast
AGENCY:
Food and Drug Administration,
HHS
ACTION:
E:\FR\FM\19JYR1.SGM
Final rule.
19JYR1
Agencies
[Federal Register Volume 72, Number 138 (Thursday, July 19, 2007)]
[Rules and Regulations]
[Pages 39557-39560]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-13947]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 179
[Docket No. 1994F-0008 (formerly Docket No. 94F-0008)]
Irradiation in the Production, Processing and Handling of Food
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule; response to objections and denial of requests for a
hearing.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is responding to
objections and is denying the requests that it has received for a
hearing on the final rule that amended the food additive regulations to
authorize the use of a machine source of high energy x-rays to inspect
cargo containers that may contain food. After reviewing the objections
to the final rule and the requests for a hearing, the agency has
concluded that the objections do not raise issues of material fact that
justify a hearing or otherwise provide a basis for revoking or
modifying the amendment to the regulation.
FOR FURTHER INFORMATION CONTACT: Andrew J. Zajac, Center for Food
Safety and Applied Nutrition (HFS-265), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park, MD 20740-3835, 301-436-1267.
SUPPLEMENTARY INFORMATION:
I. Introduction
In the Federal Register of February 24, 1994 (59 FR 8995), FDA
published a notice announcing the filing of a petition (FAP 4M4407)
submitted by Analytical Systems Engineering Corp. (ASEC) (now ACS
Defense, Inc.) to amend the food additive regulations in Sec. 179.21
Sources of radiation used for inspection of food, for inspection of
packaged food, and for controlling food processing (21 CFR 179.21) to
provide for the safe use of machine sources of high energy x-rays to
inspect cargo containers that may contain food. The rights to the
petition were subsequently transferred to R. F. Reiter and Associates.
In response to the petition, FDA issued a final rule in the Federal
Register of April 10, 2001 (66 FR 18537), permitting the use of x-rays
produced by machine sources of 10 million electron volts (MeV) or lower
to inspect food, providing that no food receives a dose in excess of
0.5 gray (Gy). This rule will be referred to in this document as the
``cargo inspection final rule.'' The preamble to the final rule advised
that objections to the final rule and requests for a hearing were due
within 30 days of the publication date (i.e., by May 10, 2001).
II. Objections and Requests for a Hearing
Section 409(f) of the Federal Food, Drug, and Cosmetic Act (the
act) (21 U.S.C. 348(f)), provides that, within 30 days after
publication of an order relating to a food additive regulation, any
person adversely affected by such order may file objections,
``specifying with particularity the provisions of the order deemed
objectionable, stating reasonable grounds therefor, and requesting a
public hearing upon such objections.'' FDA may deny a hearing request
if the objections to the regulation do not raise genuine and
substantial issues of fact that can be resolved at a hearing.
(Community Nutrition Institute v. Young, 773 F. 2d 1356, 1364 (D.C.
Cir. 1985), cert. denied, 475 U.S. 1123 (1986)).
Under the food additive regulations at 21 CFR 171.110, objections
and requests for a hearing are governed by part 12 (21 CFR part 12) of
FDA's regulations. Under Sec. 12.22(a), each objection must meet the
following conditions: (1) Must be submitted on or before the 30th day
after the date of publication of the final rule; (2) must be separately
numbered; (3) must specify with particularity the provision of the
regulation or proposed order objected to; (4) must specifically state
each objection on which a hearing is requested; failure to request a
hearing on an objection constitutes a waiver of the right to a hearing
on that objection; and (5) must include a detailed description and
analysis of the factual information to be presented in support of the
objection if a hearing is requested; failure to include a description
and analysis for an objection constitutes a waiver of the right to a
hearing on that objection.
Following publication of the cargo inspection final rule, FDA
received a letter from Public Citizen within the 30-day objection
period. Public Citizen sought revocation of the final rule based on
three objections and requested a hearing on issues raised by each
objection.
III. Standards for Granting a Hearing
Specific criteria for deciding whether to grant or deny a request
for a hearing are set out in Sec. 12.24(b). Under that regulation, a
hearing will be granted if the material submitted by the requester
shows, among other things, the following: (1) There is a genuine and
substantial factual issue for resolution at a hearing; a hearing will
not be granted on issues of policy or law; (2) the factual issue can be
resolved by available and specifically identified reliable evidence; a
hearing will not be granted on the basis of mere allegations or denials
or general descriptions of positions and contentions; (3) the data and
information submitted, if established at a hearing, would be adequate
to justify resolution of the factual issue in the way sought by the
requestor; a hearing will be denied if the data and information
submitted are insufficient to justify the factual determination urged,
even if accurate; (4) resolution of the factual issue in the way sought
by the person is adequate to justify the action requested; a hearing
will not be granted on factual issues that are not determinative with
respect to the action requested (e.g., if the action would be the same
even if the factual issue were resolved in the way sought); (5) the
action requested is not inconsistent with any provision in the act or
any FDA regulation; and (6) the requirements in other applicable
regulations, e.g., 21 CFR 10.20, Sec. Sec. 12.21 and 12.22, and in the
notice issuing the final requlation or
[[Page 39558]]
the notice of opportunity for hearing are met.
A party seeking a hearing is required to meet a ``threshold burden
of tendering evidence suggesting the need for a hearing'' (Costle v.
Pacific Legal Foundation, 445 U.S. 198, 214-215 (1980), reh. denied,
446 U.S. 947 (1980), citing Weinberger v. Hynson, Westcott & Dunning,
Inc., 412 U.S. 609, 620-621 (1973)). An allegation that a hearing is
necessary to ``sharpen the issues'' or to ``fully develop the facts''
does not meet this test (Georgia Pacific Corp. v. EPA, 671 F.2d 1235,
1241 (9th Cir. 1982)). If a hearing request fails to identify any
factual evidence that would be the subject of a hearing, there is no
point in holding one. In judicial proceedings, a court is authorized to
issue summary judgment without an evidentiary hearing whenever it finds
that there are no genuine issues of material fact in dispute and a
party is entitled to judgment as a matter of law (see Rule 56, Federal
Rules of Civil Procedure). The same principle applies in administrative
proceedings (see Sec. 12.28).
A hearing request must not only contain evidence, but that evidence
should raise a material issue of fact concerning which a meaningful
hearing might be held (Pineapple Growers Ass'n v. FDA, 673 F.2d 1083,
1085 (9th Cir. 1982)). Where the issues raised in the objection are,
even if true, legally insufficient to alter the decision, the agency
need not grant a hearing (see Dyestuffs and Chemicals, Inc. v.
Flemming, 271 F.2d 281 (8th Cir. 1959), cert. denied, 362 U.S. 911
(1960)). FDA need not grant a hearing in each case where an objector
submits additional information or posits a novel interpretation of
existing information (see United States v. Consolidated Mines &
Smelting Co., 455 F.2d 432 (9th Cir. 1971)). In other words, a hearing
is justified only if the objections are made in good faith and if they
``draw in question in a material way the underpinnings of the
regulation at issue'' (Pactra Industries v. CPSC, 555 F.2d 677 (9th
Cir. 1977)). Finally, courts have uniformly recognized that a hearing
need not be held to resolve questions of law or policy (see Citizens
for Allegan County, Inc. v. FPC, 414 F.2d 1125 (D.C. Cir. 1969); Sun
Oil Co. v. FPC, 256 F.2d 233, 240 (5th Cir.), cert. denied, 358 U.S.
872 (1958)).
Even if the objections raise material issues of fact, FDA need not
grant a hearing if those same issues were adequately raised and
considered in an earlier proceeding. Once an issue has been so raised
and considered, a party is estopped from raising that same issue in a
later proceeding without new evidence. The various judicial doctrines
dealing with finality can be validly applied to the administrative
process. In explaining why these principles ``self-evidently'' ought to
apply to an agency proceeding, the U.S. Court of Appeals for the
District of Columbia Circuit wrote: ``The underlying concept is as
simple as this: Justice requires that a party have a fair chance to
present his position. But overall interests of administration do not
require or generally contemplate that he will be given more than a fair
opportunity.'' Retail Clerks Union, Local 1401 v. NLRB, 463 F.2d 316,
322 (D.C. Cir. 1972). (See Costle v. Pacific Legal Foundation, supra at
215-220. See also Pacific Seafarers, Inc. v. Pacific Far East Line,
Inc., 404 F.2d 804 (D.C. Cir. 1968), cert denied, 393 U.S. 1093
(1969).)
In summary, a hearing request must present sufficient credible
evidence to raise a material issue of fact and the evidence must be
adequate to resolve the issue as requested and to justify the action
requested.
IV. Analysis of Objections and Response to Hearing Requests
The objections to the cargo inspection final rule pertain to FDA's
safety determination. FDA addresses each of the objections below, as
well as the data and information filed in support of each, comparing
each objection and the information submitted in support of it to the
standards for granting a hearing in Sec. 12.24.
A. Safety of Irradiation for Inspection of Cargo Containers
Under 21 CFR 170.3(i), safety of a food additive means that there
is a reasonable certainty in the minds of competent scientists that the
substance is not harmful under the intended conditions of use. FDA's
regulations reflect the congressional judgment that the additive must
be properly tested and such tests carefully evaluated, but that the
additive need not, indeed cannot, be shown to be safe to an absolute
certainty. The House Report on the Food Additives Amendment of 1958
stated: ``Safety requires proof of a reasonable certainty that no harm
will result from the proposed use of the additive. It does not--and
cannot--require proof beyond any possible doubt that no harm will
result under any conceivable circumstance'' (H. Rept. 2284, 85th Cong.,
2d sess., 1958).
The cargo inspection final rule discussed in detail FDA's
evaluation of the safety of radiation for inspection of cargo
containers that may contain food (66 FR 18537). Under that regulation,
machine sources producing x-rays at energies no greater than 10 MeV may
be used to inspect containers of food, provided that the absorbed dose
not exceed 0.5 Gy.
Among the reports submitted in the petition or that FDA identified
in scientific publications, the agency explicitly cited three in its
final rule. These reports, which were among the most recent studies or
reviews, assessed the potential for induced radioactivity in food by
experimental measurement and theoretical calculation, and provided the
primary basis for FDA's conclusion regarding safety of the petitioned
use of 10 MeV x-rays at a dose not to exceed 0.5 Gy.
One of the reports is from the World Health Organization (WHO).
This WHO report concluded that no detectable radioactivity will be
induced in foodstuffs by x-rays with a maximum energy level of 10 MeV
when a radiation dose of 0.5 Gy is not exceeded.
The second report (Wakeford and Blackburn, 1991) discussed a study
investigating the radioactivity induced in codfish, rice, and a
macerated meat product irradiated with high energy bremsstrahlung\1\ x-
rays produced by an electron linear accelerator that generated
electrons at energies up to 12 MeV and predominantly at 8 MeV. The
authors reported that the bremsstrahlung x-rays used to irradiate the
food had a maximum energy in the region of 10 MeV. These foods received
radiation doses ranging from 8.8 to 14 kilogray (kGy), which is 17,600
to 28,000 times higher than the 0.5 Gy maximum dose permitted by the
final rule. Induced activities in the foods from the bremsstrahlung x-
rays were reported to be extremely small and of the same order as
natural background levels, and any induced activities dropped quickly.
---------------------------------------------------------------------------
\1\Bremsstrahlung refers to the type of x-rays that are emitted
when high-speed electrons are suddenly decelerated due to
interactions with atomic nuclei. X-rays also can be produced when
accelerated electrons have sufficient energy to eject electrons from
the inner shells of atoms. As outer-shell electrons move in to fill
the vacancies in the lower energy level, x-rays are emitted, called
characteristic x-rays.
---------------------------------------------------------------------------
The third report (Findlay et al., 1992) summarized a study that
investigated the induced radioactivity in chicken, prawns, cheeses, and
spices irradiated with electron beams at two energies, 10 MeV and 20
MeV and at different doses up to 10 kGy. The authors noted that any
induced radioactivity was due to photonuclear reactions resulting from
bremsstrahlung x-rays and electronuclear reactions induced by the
electron beams. The authors found that even when the food was
irradiated with
[[Page 39559]]
electrons at 20 MeV and doses at 10 kGy, the highest energy and dose
tested, any induced activity was negligible after 1 day.\2\ The authors
reported that the measured values agreed well with calculated values.
Based on the totality of the data and other relevant material evaluated
by FDA, the agency concluded that no detectable radioactivity will be
induced in food when an x-ray energy of 10 MeV and a dose of 0.5 Gy are
not exceeded, and that the use of x-rays, produced by a machine source
at energies of 10 MeV or lower, to inspect food, is safe.
---------------------------------------------------------------------------
\2\ The authors reported a specific activity after 1 day of 0.01
becquerel/gram.
---------------------------------------------------------------------------
B. Objections
Public Citizen contends that FDA has failed to demonstrate that the
use of the subject additive is safe and gives three reasons for
objecting to the final rule. Public Citizen requests a public hearing
on their objections.
First, Public Citizen contends that FDA's use of the conclusion in
the WHO report that ``no detectable radioactivity will be induced in
foodstuffs when an x-ray energy level of 10 MeV and a dose of 0.5 Gy
are not exceeded'' is flawed because the conclusion is based on an
extrapolation of theoretical and experimental studies that the report
does not reference.
The WHO report states that ``* * * relevant experimental data are
available from studies designed to evaluate the use of activation
analysis and the application of x-rays and electrons in food
irradiation and medical uses at energy levels up to 24 MeV and at doses
up to 50 kGy. Such studies, both theoretical and experimental, can be
used to extrapolate downwards to a lower dose such as the 0.5 Gy
considered for surveillance systems and that these studies show no
evidence that detectable levels of radioactivity would be induced at
these lower doses.'' Although not specifically cited, it is clear that
the experimental data referred to in the report are the data from
studies that were discussed in several working papers that were
presented to the WHO consultation group and several relevant published
papers referenced in the WHO report. These working papers were included
in the petition along with the WHO report. For example, one paper that
discussed experimental and theoretical work concerning the possible
induction of radionuclides in food by high energy x-ray systems used
for cargo surveillance referenced several relevant studies, including
one by Glass and Smith.\3\ This particular study, which was submitted
with the petition, examined isomer radioactivities in elements and food
using a variety of radiation sources, including 4-24 MeV x-ray sources
at doses up to 50 kGy. FDA is denying the request for a hearing on this
point because a hearing will not be granted if there is no genuine and
substantial factual issue to be resolved (Sec. 12.24(b)(1)).
---------------------------------------------------------------------------
\3\ R.A. Glass and H.D. Smith, ``Radioactive Isomer Production
in Foods by Gamma Rays and X-rays,'' Stanford Research Institute
Report S-594, No. 3 (DA 19-129-1QM-1511), 1960.
---------------------------------------------------------------------------
Public Citizen has failed to submit any evidence that would call
into question the scientific validity of extrapolation of results
obtained at higher energy levels and radiation doses to draw
conclusions regarding effects that might be produced at lower energy
levels and doses. Public Citizen is merely alleging that this approach
is scientifically unsound. FDA is denying the request for a hearing on
this point because a hearing will not be granted on the basis of mere
allegations or denials or general descriptions of positions or
contentions (Sec. 12.24(b)(2)).
In its second objection, Public Citizen contends that the Wakeford
report is cited in the final rule to support the statement that
electrons with energies of 8-10 MeV induced an extremely small level of
radioactivity in various types of food, but that this statement is
irrelevant to this petition because the petition concerns the use of x-
rays. The objection further asserts that the statement in the final
rule ``FDA would not expect any detectable radioactivity above
background in food resulting from the petitioned use,'' is based on no
data or evidence.
Contrary to Public Citizen's contention, the Wakeford report did
concern the use of x-rays. As referenced in the final rule, the report
by Wakeford, Blackburn, and Swallow (FDA inadvertently omitted the name
of the third co-author, A.J. Swallow), titled ``Induction and Detection
of Radioactivity in Foodstuffs Irradiated with 10 MeV Electrons and X-
rays,'' studied food irradiated with electron beams as well as with
high energy bremsstrahlung x-rays. The authors state that the food was
irradiated directly by 0-10 MeV x-rays to a maximum dose of 15-20 kGy
(the results table shows an average dose ranging from 8.8 to 14 kGy,
which is 17,600 to 28,000 times higher than the maximum permitted dose
level under the final rule of 0.5 Gy). The authors concluded that the
induced activity from the 0-10 MeV bremsstrahlung x-rays was extremely
small. Public Citizen provided no information to support its contention
that the radiation reported as x-rays in the Wakeford report is
irrelevant to the safety review of the subject additive. FDA is denying
the request for a hearing on this point because a hearing will not be
held on the basis of mere allegations or denials or general
descriptions of positions or contentions (Sec. 12.24(b)(2)).
Similarly, the objection does not identify any evidence to support
its assertion that FDA's conclusion is based on no data or evidence.
The data and evidence relied upon by FDA is set out in the final rule.
The Wakeford report, the WHO report and Findlay report are all part of
the data relied upon by FDA in making its determination. FDA is denying
the request for a hearing on this point because a hearing will not be
held on the basis of mere allegations or denials or general
descriptions of positions or contentions (Sec. 12.24(b)(2)).
Public Citizen also states in its second objection that, according
to the Wakeford report, x-rays of energy greater than 3 MeV could
induce radioactivity, and four isotopes can be activated at x-ray
energies below 5 MeV and cause neutron induced activity in food. Among
the four isotopes, Public Citizen specifically mentions carbon-13,
oxygen-17, and deuterium. The objection does not show that FDA failed
to consider important information that would have altered the agency's
conclusion that the x-rays at energies up to 10 MeV at the maximum
proposed dose of 0.5 Gy will result in negligible amounts of induced
radioactivity in food. Indeed, the WHO report cited in the final rule
concluded that thresholds for inducing radioactivity in some isotopes
is less than 10 MeV, but that the probability of radioactivity being
induced under these conditions is so low that it would not be detected
by methods that can determine activity that is only 1 percent of what
occurs naturally in food. The language from the Wakeford report cited
in the objection is consistent with the conclusions in the WHO report.
Public Citizen identifies no information to support a conclusion
contrary to that reached by FDA. Therefore, FDA is denying the request
for a hearing on this point because a hearing will not be held if there
is no factual issue that can be resolved by available and specifically
identified reliable evidence (Sec. 12.24(b)(2)).
In its third objection, Public Citizen states that the Findlay
report is not relevant to the petition because induction of
radioactivity in food was studied using electron beams whereas the
petition concerns the use of x-rays.
[[Page 39560]]
In support of its assertion, Public Citizen references a report from
the International Consultative Group on Food Irradiation titled ``The
Development of X-Ray Machines for Food Irradiation (Proceedings of a
Consultants' Meeting),'' dated October 1995 (ICGFI report), for its
statement that ``neutron activity produced by 5 MeV x-rays is in the
order of 60 times greater than that produced by 10 MeV electrons.''
However, contrary to Public Citizen's objection, the ICGFI report
shows that the difference in expected neutron activation in irradiated
food from electron beams and x-rays has been calculated, thereby
permitting use of electron beam studies to estimate neutron activation
expected from irradiation with x-rays. Public Citizen has offered no
evidence to support its assertion that electron beam studies are
inappropriate to support conclusions about x-ray irradiation. FDA is
denying the request for a hearing on this point because the evidence
submitted by Public Citizen in support of their argument, even if
established at a hearing, would not be adequate to justify resolution
of the factual issue in the way sought by the objector (Sec.
12.24(b)(3)).
Moreover, it bears noting that the ICGFI report directly supports
FDA's conclusion of safety in the final rule, when it cites 10 MeV x-
rays at doses less than 0.5 Gy (the maximum energy and dosage in the
final rule) as an example of ``extremely low'' dosage that ``would not
produce any significant radioactivity.'' Public Citizen's reference to
the conclusion in the ICGFI report that ``increasing the energy of x-
rays above 7.5 MeV would result in * * * possible induction of
radioactivity in the irradiated food'' is unavailing because that
conclusion refers to the uses permitted by the Codex Alimentarius
Commission for treating food at dosages up to 10 kGy, which is 20,000
times higher than the 0.5 Gy maximum dosage permitted by the final rule
for inspecting food.
Although Public Citizen alleged that the studies that FDA evaluated
do not support the safety of x-rays of 10 MeV or lower used for
inspection of cargo containers that may contain food, Public Citizen
did not present any evidence that would have led to a different
conclusion concerning the safety of the subject additive. Because
Public Citizen's first and second objections provided no information to
support their assertions regarding FDA's safety review, they provide no
basis for FDA to reconsider its decision to issue the cargo inspection
final rule. As noted previously, a hearing will not be granted on the
basis of general descriptions of positions and contentions (see Sec.
12.24(b)(1) and (b)(2)). Public Citizen's third objection relied on
information that, even if established at a hearing, would not be
adequate to justify resolution of the factual issue in the way sought
by the objector. A hearing will be denied if the information submitted
are insufficient to justify the factual determination urged, even if
accurate (Sec. 12.24(b)(3)). The issues posed by Public Citizen in
support of the objections do not justify the granting of a hearing.
V. Summary and Conclusions
The safety of x-rays produced by a machine source at energies of 10
MeV or lower, to inspect food irradiated at doses up to 0.5 Gy has been
thoroughly tested, and the data have been reviewed by the agency. As
discussed previously, FDA concluded that the available studies
establish the safety of food for human consumption irradiated at doses
up to 0.5 Gy as a result of being subjected to x-rays produced by a
machine source at energies of 10 MeV or lower. The petitioner has the
burden to demonstrate safety before FDA can approve the use of a food
additive. Nevertheless, once the agency makes a finding of safety in an
approval document, the burden shifts to an objector, who must come
forward with evidence that calls into question FDA's conclusion
(American Cyanamid Co. v. FDA, 606 F. 2d 1307, 1314-1315 (D.C. Cir.
1979)). For the reasons set out previously, the objections do not raise
genuine and substantial issues of fact supported by specifically
identified reliable evidence that, if established at a hearing would be
adequate to justify resolution in the way sought by Public Citizen.
Therefore, Public Citizen's objections are not sufficient to justify a
hearing under the requirements of Sec. 12.24(b). Accordingly, FDA is
overruling the objections and is denying the requests for a hearing.
Dated: July 11, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7-13947 Filed 7-18-07; 8:45 am]
BILLING CODE 4160-01-S